ClinicalTrials.Veeva

Menu

Prospective Clinical Observational Cohort Study to Evaluate the Use of a Tissue Separating Mesh (Proceed®) in Laparoscopic Ventral Hernia Repair

G

Ghent University Hospital (UZ)

Status

Completed

Conditions

Ventral Hernia

Treatments

Procedure: use of a tissue separating mesh (Proceed®) in Laparoscopic Ventral hernia repair

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT00572962
2007/268

Details and patient eligibility

About

  1. General: antibiotic prophylaxis: cefazoline (Cefacidal™) 2 gram iv administered 30 minutes before surgery

  2. Laparoscopic surgery

    • at least 5 cm overlap (mesh diameter should exceed hernia size by at least 10 cm)
    • with or without anchoring transparietal sutures or double crown technique

Enrollment

210 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • written informed consent from the patient or his/her legal representative
  • ventral hernia requiring elective surgical repair

Exclusion criteria

  • no written informed consent
  • 'hostile' abdomen; open abdomen treatment
  • contraindication to pneumoperitoneum
  • emergency surgery (incarcerated hernia)
  • parastomal hernia

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

210 participants in 1 patient group

1
Experimental group
Description:
use of a tissue separating mesh (Proceed®) in Laparoscopic Ventral hernia repair
Treatment:
Procedure: use of a tissue separating mesh (Proceed®) in Laparoscopic Ventral hernia repair

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems